Uterine Cancer is localized in the uterus and is frequently referred to as endometrial cancer because it forms in the lining of the uterus (the endometrium). Uterine cancer is the fourth most common cancer in women and is the most frequently diagnosed gynecologic cancer. It usually occurs during/after menopause and risk in increased with obesity and taking estrogenalone hormone replacement therapy. Treatment is typically a hysterectomy, removal the uterus, ovaries, and fallopian tubes but hormone therapy and radiation are other treatment options if found appropriate.
Uterine Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Uterine Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 2221 products for the study of Uterine Cancer that can be applied to Flow Cytometry, Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.